Glutamate signalling in bone: a therapeutic target for osteoporosis?

ISSN： 1472-8222

Source： Expert Opinion on Therapeutic Targets, Vol.4, Iss.2, 2000-04, pp. : 207-218

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Glutamate Signalling in Bone.

Current Pharmaceutical Design, Vol. 7, Iss. 8, 2001-05 ,pp. : 737-750

Bentham Science Publishers

Access to resources Recommend Favorite

Wnt signalling pathway: a new target for the treatment of osteoporosis

By Rawadi Georges Roman-Roman Sergio

Expert Opinion on Therapeutic Targets, Vol. 9, Iss. 5, 2005-10 ,pp. : 1063-1077

Informa Healthcare

Access to resources Recommend Favorite

Activin Receptor Signaling: A Potential Therapeutic Target for Osteoporosis

Current Molecular Pharmacology, Vol. 5, Iss. 2, 2012-06 ,pp. : 195-204

Bentham Science Publishers

Access to resources Recommend Favorite

gp130-mediated signalling as a therapeutic target

By Ohtani T. Ishihara K. Atsumi T. Yoshida Y. Nishida K. Narimatsu M. Shirogane T. Hibi M. Hirano T.

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 4, 2000-08 ,pp. : 459-479

Informa Healthcare

Access to resources Recommend Favorite

TGF-&bgr; Pathway as a Therapeutic Target in Bone Metastases

Current Pharmaceutical Design, Vol. 16, Iss. 11, 2010-04 ,pp. : 1301-1312

Bentham Science Publishers

Access to resources Recommend Favorite